About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN
My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Viral Immunology

Editor-in-Chief: David L. Woodland

ISSN: 0882-8245 • 10 Issues Annually • Online ISSN: 1557-8976

Current Volume: 27

Latest Impact Factor* is 1.636

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    Your paper will undergo peer review. You will be advised whether it is acceptable and if so whether revisions have been recommended.


    Manuscripts must be submitted online using the following url: http://mc.manuscriptcentral.com/viral

    Please read all the instructions to authors before submitting.

    The Journal will publish both full and short communications. Full communications should be prepared as described below; short communications do not need compartmentalization and should be limited to a maximum of two tables or two figures, or one of each. Contributions to the Journal are published at no charge to the author. Manuscripts should be submitted with the understanding that they have neither been previously published, nor are they under consideration elsewhere. Authors will be allowed to indicate one reviewer who should be excluded from review of their manuscript.

    PREPARATION OF MANUSCRIPT

    NOTE: 

    All submitted manuscripts will be processed through plagiarism detection software.  Plagiarized manuscripts will be rejected immediately.

     

    Papers must be submitted via upload in a word processing format, preferably in Microsoft Word. Please do not include artwork within the text document. Figures and tables should be supplied in separate files, be labeled clearly, and should be in TIFF or EPS formats. Please see the Tables and Illustrations section for futher details on art submission.

     

    TABLES AND ILLUSTRATIONS 

    Electronic submission of art MUST follow these guidelines:

     

    • Do not include any illustrations as part of your text file.
    • Do not prepare any figures in Word as they are not workable.
    • Line illustrations must be submitted at 900 DPI.
    • Halftones and color photos should be submitted at 300 DPI.
    • Please submit only TIFF or EPS files.
    • Tables should be submitted in Word.
    • Color art must be saved as CYMK not RGB or INDEX.  If RGB files are submitted, the files will be converted to CYMK, and some slight color variation may occur.
    • When naming your figure files, please label them with the first author’s last name followed by Figure 1.,  Figure 2,, etc.  Label figures and tables inside the files in addition to naming the file with the figure or table number. (i.e.: When figures or table files are opened, the figure or table number should appear inside the file.)
    • PowerPoint or Excel files cannot be uploaded.

     

    1)  Tables should be typed double spaced, one to a page and are placed after the references.  2)  Legends for tables go above the table.  Capitalize TABLE 1., etc. with Arabic numerals.  3) Capitalize FIGURE 1., etc. and set it to the left of the title on the same line.  Remember, each table must stand alone, i.e., contain all necessary information in the caption, and the table itself must be understood independently of the text.  Do not repeat information that is given in the text, and do not make a table for data which can be given in the text in one or two sentences.
     

    FOOTNOTES

    Footnotes should be typed double spaced on a separate page. They should be used only when essential.

     

    ACKNOWLEDGMENTS

    Collaborations, sources of research funds, and other acknowledgments should be listed in a separate section at the end of the text ahead of the reference section.

     

    Disclosure Statement

    Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."


    LITERATURE CITED. (1) References should be listed in alphabetical order but are cited in the text by number in parentheses. (2) List all the authors, inverting the name of the first one only. (3) The order of the other elements is: year, title of paper, journal, volume, and inclusive page numbers. Please be certain all reference citations are accurate, as we do not check them. For a book, the order is: authors, year, chapter title, inclusive pages, editor(s) name(s), book title, publisher, city of publication. Papers that are in preparation or submitted (but not yet accepted) should be mentioned in parentheses in the text; they should not be included as LITERATURE CITED.

     

    Please upload individual files of all manuscript material – do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.

     

    PERMISSIONS

    The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher (not the author or editor) of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, the first footnote of a reprinted table, or the last sentence of the legend of a reprinted figure, should read "reprinted by permission from Ref. (00)" and list appropriate reference number.

     

    REPRINTS

    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

     

    PUBLISHER

    The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, New York 10801-5215. Telephone: (914) 740-2100; fax: (914) 740-2101; E-mail: info@liebertpub.com internet: www.liebertpub.com

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy


    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

     

    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 

     

     

     

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    AIDS Research and Human Retroviruses

    AIDS Research and Human Retroviruses

    The leading journal in the field for over 25 years, providing the latest developments and research advances in HIV/AIDS and other retroviruses leading to improvements in translational medicine for optimal treatment outcomes.

    Journal of Interferon
    & Cytokine Research

    Journal of Interferon
    & Cytokine Research

    Presents the latest findings and reviews of research covering IFNs and cytokines, their relevance to chronic and acute disease, studies involving cytokine biology, mechanisms of IFN action, and their role in virus infection.

    DNA and Cell Biology

    DNA and Cell Biology

    Combining mechanistic and clinical studies from multiple systems in a single resource, the Journal delivers authoritative, peer-reviewed reporting on the latest research in the field of molecular biology.

Browse All Publications »